This study was conducted to investigate the role of chemotherapies in priming tumor-antigen-specific CD8+ TTSM cells in TdLNs and in shaping the intratumoral CD8+ Tpex cell response across various tumor models. This evidence concerns the gene CD8A and neoplasm.